ROIV Competitors & Alternatives
Compare Roivant Sciences Ltd with similar stocks in the same industry
Biotechnology
ROIV
Main Stock$40.82
Tradestie Score
39
Market Cap
$10.76B
Revenue Growth
-0.3%
Analyst Upside
+11.7%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARGX
argenx SE American Depositary Shares
|
$984.39
|
$46.96B | 38.4 | 43 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$346.51
|
$36.81B | 62.8 | 48 | Compare |
|
INSM
Insmed, Inc.
|
$129.41
|
$31.13B | - | 54 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$96.73
|
$24.57B | - | 37 | Compare |
|
GMAB
Genmab A/S ADS
|
$32.47
|
$19.56B | 26.2 | 41 | Compare |
|
INCY
Incyte Genomics Inc
|
$121.47
|
$16.93B | 15.9 | 50 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$58.61
|
$15.70B | 32.6 | 52 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$17.55
|
$15.22B | - | 41 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$263.52
|
$12.36B | 20.8 | 47 | Compare |
|
EXEL
Exelixis Inc
|
$56.12
|
$11.09B | 18.3 | 41 | Compare |
More ROIV Analysis
Data updated: Sep 11, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry